164 related articles for article (PubMed ID: 33340567)
21. Thermodynamics of aggregate formation between a non-ionic polymer and ionic surfactants: An isothermal titration calorimetric study.
Patel SG; Bummer PM
Int J Pharm; 2017 Jan; 516(1-2):131-143. PubMed ID: 27789368
[TBL] [Abstract][Full Text] [Related]
22. Investigation into the Solid-State Properties and Dissolution Profile of Spray-Dried Ternary Amorphous Solid Dispersions: A Rational Step toward the Design and Development of a Multicomponent Amorphous System.
Baghel S; Cathcart H; O'Reilly NJ
Mol Pharm; 2018 Sep; 15(9):3796-3812. PubMed ID: 30020788
[TBL] [Abstract][Full Text] [Related]
23. A win-win solution in oral delivery of lipophilic drugs: supersaturation via amorphous solid dispersions increases apparent solubility without sacrifice of intestinal membrane permeability.
Miller JM; Beig A; Carr RA; Spence JK; Dahan A
Mol Pharm; 2012 Jul; 9(7):2009-16. PubMed ID: 22632106
[TBL] [Abstract][Full Text] [Related]
24. Maintaining Supersaturation of Nimodipine by PVP with or without the Presence of Sodium Lauryl Sulfate and Sodium Taurocholate.
Pui Y; Chen Y; Chen H; Wang S; Liu C; Tonnis W; Chen L; Serno P; Bracht S; Qian F
Mol Pharm; 2018 Jul; 15(7):2754-2763. PubMed ID: 29782805
[TBL] [Abstract][Full Text] [Related]
25. Thermodynamics of Highly Supersaturated Aqueous Solutions of Poorly Water-Soluble Drugs-Impact of a Second Drug on the Solution Phase Behavior and Implications for Combination Products.
Trasi NS; Taylor LS
J Pharm Sci; 2015 Aug; 104(8):2583-93. PubMed ID: 26059413
[TBL] [Abstract][Full Text] [Related]
26. Exploration of supersaturable lacidipine ternary amorphous solid dispersion for enhanced dissolution and in vivo absorption.
Guan J; Jin L; Liu Q; Xu H; Wu H; Zhang X; Mao S
Eur J Pharm Sci; 2019 Nov; 139():105043. PubMed ID: 31415903
[TBL] [Abstract][Full Text] [Related]
27. Mechanistic elucidation of formation of drug-rich amorphous nanodroplets by dissolution of the solid dispersion formulation.
Ueda K; Higashi K; Moribe K
Int J Pharm; 2019 Apr; 561():82-92. PubMed ID: 30822504
[TBL] [Abstract][Full Text] [Related]
28. Drug Release from Surfactant-Containing Amorphous Solid Dispersions: Mechanism and Role of Surfactant in Release Enhancement.
Yang R; Zhang GGZ; Zemlyanov DY; Purohit HS; Taylor LS
Pharm Res; 2023 Dec; 40(12):2817-2845. PubMed ID: 37052841
[TBL] [Abstract][Full Text] [Related]
29. Impact of Eudragit EPO and hydroxypropyl methylcellulose on drug release rate, supersaturation, precipitation outcome and redissolution rate of indomethacin amorphous solid dispersions.
Xie T; Gao W; Taylor LS
Int J Pharm; 2017 Oct; 531(1):313-323. PubMed ID: 28844901
[TBL] [Abstract][Full Text] [Related]
30. Formulation performance and processability window for manufacturing a dual-polymer amorphous solid dispersion via hot-melt extrusion and strand pelletization.
Hörmann TR; Jäger N; Funke A; Mürb RK; Khinast JG; Paudel A
Int J Pharm; 2018 Dec; 553(1-2):408-421. PubMed ID: 30326284
[TBL] [Abstract][Full Text] [Related]
31. Supersaturation and phase behavior during dissolution of amorphous solid dispersions.
Kong Y; Wang W; Wang C; Li L; Peng D; Tian B
Int J Pharm; 2023 Jan; 631():122524. PubMed ID: 36549404
[TBL] [Abstract][Full Text] [Related]
32. Curcumin amorphous solid dispersions benefit from hydroxypropyl methylcellulose E50 to perform enhanced anti-inflammatory effects.
Zhang J; Shi X; Tao W
Int J Biol Macromol; 2023 Dec; 252():126507. PubMed ID: 37633564
[TBL] [Abstract][Full Text] [Related]
33. Origin of Nanodroplet Formation Upon Dissolution of an Amorphous Solid Dispersion: A Mechanistic Isotope Scrambling Study.
Indulkar AS; Waters JE; Mo H; Gao Y; Raina SA; Zhang GGZ; Taylor LS
J Pharm Sci; 2017 Aug; 106(8):1998-2008. PubMed ID: 28431965
[TBL] [Abstract][Full Text] [Related]
34. Toward Developing Discriminating Dissolution Methods for Formulations Containing Nanoparticulates in Solution: The Impact of Particle Drift and Drug Activity in Solution.
Arce FA; Setiawan N; Campbell HR; Lu X; Nethercott MJ; Bummer P; Su Y; Marsac PJ
Mol Pharm; 2020 Nov; 17(11):4125-4140. PubMed ID: 32965123
[TBL] [Abstract][Full Text] [Related]
35. Biopharmaceutical Understanding of Excipient Variability on Drug Apparent Solubility Based on Drug Physicochemical Properties: Case Study-Hypromellose (HPMC).
Zarmpi P; Flanagan T; Meehan E; Mann J; Fotaki N
AAPS J; 2020 Feb; 22(2):49. PubMed ID: 32072317
[TBL] [Abstract][Full Text] [Related]
36. Impact of surfactant selection and incorporation on in situ nanoparticle formation from amorphous solid dispersions.
Yen CW; Kuhn R; Hu C; Zhang W; Chiang PC; Chen JZ; Hau J; Estevez A; Nagapudi K; Leung DH
Int J Pharm; 2021 Sep; 607():120980. PubMed ID: 34371147
[TBL] [Abstract][Full Text] [Related]
37. Improved oral absorption of tacrolimus by a solid dispersion with hypromellose and sodium lauryl sulfate.
Jung HJ; Ahn HI; Park JY; Ho MJ; Lee DR; Cho HR; Park JS; Choi YS; Kang MJ
Int J Biol Macromol; 2016 Feb; 83():282-7. PubMed ID: 26642839
[TBL] [Abstract][Full Text] [Related]
38. Compromised in vitro dissolution and membrane transport of multidrug amorphous formulations.
Alhalaweh A; Bergström CAS; Taylor LS
J Control Release; 2016 May; 229():172-182. PubMed ID: 27006280
[TBL] [Abstract][Full Text] [Related]
39. Impact of Surfactants on the Performance of Clopidogrel-Copovidone Amorphous Solid Dispersions: Increased Drug Loading and Stabilization of Nanodroplets.
Correa Soto CE; Gao Y; Indulkar AS; Ueda K; Zhang GGZ; Taylor LS
Pharm Res; 2022 Jan; 39(1):167-188. PubMed ID: 35013849
[TBL] [Abstract][Full Text] [Related]
40. In situ molecular elucidation of drug supersaturation achieved by nano-sizing and amorphization of poorly water-soluble drug.
Ueda K; Higashi K; Yamamoto K; Moribe K
Eur J Pharm Sci; 2015 Sep; 77():79-89. PubMed ID: 26036231
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
